Accelerating cancer research through knowledge exchange and multi-stakeholder discussion

To drive innovation and scientific debate in cancer research, the CDDF positions academics as a fundamental force within its multi-stakeholder community. The association provides a dedicated platform to share the latest breakthroughs in oncology and engage in cross-sector dialogue.

CDDF discussions represent unique opportunities for academics to collaborate and network with all stakeholders in oncology drug development—including industry, patient advocacy groups, Health Technology Assessment (HTA) bodies and regulatory agencies.

Join the CDDF community and contribute your expertise to our shared mission of improving cancer treatments for patients.

How CDDF Benefits Academics

To support engagement from academia, the CDDF offers complimentary registration for academic participants, along with speaker and publication opportunities and open access to the CDDF intranet. In this manner, outcomes from multi-stakeholder discussions flow back into academic research and drive future innovation.